All three earned a perfect score on the ranking of the 500 largest publicly traded companies, measured by reported in sales in the latest fiscal year and whose primary stock is listed in the United States or Canada.
The companies will merge core capabilities to deliver “best-in-class” clinical expertise, advanced analytics, and customized client experiences to serve workers' compensation clients and injured patients.
Drug and discount stores have managed to lure customers away from specialty and department stores to their doors for color cosmetics, where brows and lashes are leading the charge to attract shoppers, skin care and bubble bath products.
Sales of artificial eyelashes packaged with adhesives rose 31% to $157 million, according to IRI data for multi-outlet retailers for the 52-week period ended March 19. Eyelash adhesives kicked in another $30 million and showed growth of 24%.
Colgate-Palmolive CEO Ian Cook would be open to a $100-per-share selling price for the company, according to a New York Post source. Cook reportedly floated the price at a recent investors meeting, which took place as such companies as Unilever, Johnson & Johnson, Warren Buffett’s 3G Capital and Procter & Gamble are floated as potential suitors for an acquisition. (New York Post)